ArticleOncology reports2014

Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.

Yan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.